e-learning
resources
Paris 2018
Sunday, 16.09.2018
Asthma: clinical screening tools
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.
S. Bhargava (Mysore, India), M. P.A. (Mysore, India), A. Holla (Mysore, India), J. B.S. (Mysore, India), P. A.S. (Mysore, India), R. S (Mysore, India), S. Khurana (Rochester, United States of America)
Source:
International Congress 2018 – Asthma: clinical screening tools
Session:
Asthma: clinical screening tools
Session type:
Thematic Poster
Number:
684
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Bhargava (Mysore, India), M. P.A. (Mysore, India), A. Holla (Mysore, India), J. B.S. (Mysore, India), P. A.S. (Mysore, India), R. S (Mysore, India), S. Khurana (Rochester, United States of America). Cluster analysis identifies distinct clinical phenotypes with poor treatment responsiveness in asthma.. 684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Cluster analysis and clinical asthma phenotypes
Source: Annual Congress 2013 –Severe asthma: moving from phenotyping to endotyping
Year: 2013
Adult asthma phenotypes identified by a cluster analysis on clinical and biological characteristics
Source: International Congress 2018 – Asthma in children and adults: long-term aspects
Year: 2018
Identifying adult asthma phenotypes using a clustering approach
Source: Eur Respir J 2011; 38: 310-317
Year: 2011
Identification of clinical phenotypes using cluster analyses in COPD patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019
Cluster analysis revealed differences on quality of life and susceptibility to exacerbation between subpopulations of smokers including COPD
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
A network analysis of clinical characteristics of patients with COPD: partial results.
Source: International Congress 2018 – Chronic respiratory disease: effects of rehabilitation interventions in patients
Year: 2018
Identification of asthma phenotypes using cluster analysis
Source: International Congress 2018 – Exploring the importance of daily physical activity in chronic respiratory disease
Year: 2018
Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Cluster analysis of clinical phenotypes of OSA and its implications for comorbidities
Source: Virtual Congress 2021 – What is new for sleep apnoea? The European perspective: findings from the European Sleep Apnoea Database (ESADA)
Year: 2021
Clinical COPD phenotypes identified by cluster analysis: validation with mortality
Source: Eur Respir J 2012; 40: 495-496
Year: 2012
Cluster phenotyping as an approach to identify COPD patients at risk of poor prognosis.
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Identification of asthma clusters in two independent Korean adult asthma cohorts
Source: Eur Respir J 2013; 41: 1308-1314
Year: 2013
Longitudinal validation of clinical COPD phenotypes identified by cluster analysis
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Clinical, inflammaory and functional analysis before, during and after treatment with Omalizumabe in patients with difficulty control asthma.
Source: International Congress 2017 – Evolution or revolution in the treatment of asthma and allergies
Year: 2017
The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes
Source: ERS Lung Science Conference 2016
Year: 2016
Cluster analysis of severe life-threatening asthma: identification of a distinct phenotype characterized by high serum eosinophils
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
Temporal stability of asthma phenotypes identified by a clustering approach: An ECRHS-SAPALDIA-EGEA study
Source: Annual Congress 2012 - Asthma: from childhood environment to adult phenotypes
Year: 2012
Two phenothypes of severe asthma identified by cluster analysis
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
Clinical COPD phenotypes: a novel approach using principal component and cluster analyses
Source: Eur Respir J 2010; 36: 531-539
Year: 2010
The impact of different asthma phenotypes on the outcome
Source: Annual Congress 2012 - Asthma from childhood to adulthood: what factors predict the outcome?
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept